PRCT
insider transactionsPROCEPT BioRobotics Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $12.5M.
Net shares · 365d
+903.3K
927.5K buy · 24.2K sell
Net value · 365d
$11.9M
$12.5M in · $602.0K out
Sentiment · 365d
Net buying
95% buying · 5% selling
Open-market trades · 365d
19
927.5K buy · 24.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +61%
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +85%
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +0%
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +26%
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +3%
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +43%
-
Grant·A
Director
$0
5.9K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +9%
-
Sell·S
Kevin Waters KEY
EVP, CFO
$10.2K
357 sh · $28.48
Own -0%
-
Sell·S
EVP, Chief Technology Officer
$10.2K
358 sh · $28.48
Own -1%
-
Sell·S
EVP, CLO, CORP. SEC.
$8.1K
285 sh · $28.48
Own -0%
-
Sell·S
EVP, CLO, CORP. SEC. · 10b5-1
$61.0K
2.3K sh · $26.15
Own -2%
-
Sell·S
EVP, CLO, CORP. SEC. · 10b5-1
$78.3K
3.0K sh · $25.82
Own -3%
-
Sell·S
Kevin Waters KEY
EVP, CFO
$19.9K
706 sh · $28.15
Own -0%
-
Sell·S
EVP, CLO, CORP. SEC.
$8.6K
304 sh · $28.15
Own -0%
-
Sell·S
EVP, CLO, CORP. SEC.
$3.9K
145 sh · $26.74
Own -0%
-
Sell·S
EVP, CLO, CORP. SEC.
$79.3K
3.1K sh · $25.60
Own -3%
-
Buy·P
Director
$33.0K
1.3K sh · $25.42
Own +0%
-
Buy·P
Director
$1.3M
53.8K sh · $24.91
Own +15%
-
Buy·P
Director
$1.0M
43.6K sh · $24.08
Own +13%
-
Sell·S
Kevin Waters KEY
EVP, CFO
$159.3K
6.7K sh · $23.70
Own -4%
-
Sell·S
EVP, CLO, CORP. SEC.
$163.4K
6.9K sh · $23.70
Own -6%
-
Buy·P
Director
$1.3M
53.8K sh · $24.10
Own +20%
-
Buy·P
Director
$2.5M
106.6K sh · $23.33
Own +64%
-
Buy·P
Director, 10% Owner
$2.0M
501.3K sh · $3.99
Own +5%
-
Grant·A
Larry L Wood KEY
President, CEO
$0
103.7K sh
Own New
-
Grant·A
Larry L Wood KEY
President, CEO
$0
127.8K sh
Own +69%
-
Grant·A
Kevin Waters KEY
EVP, CFO
$0
32.6K sh
Own New
-
Grant·A
Kevin Waters KEY
EVP, CFO
$0
47.5K sh
Own +43%
-
Grant·A
Director
$0
8.9K sh
Own New
-
Grant·A
Director
$0
5.5K sh
Own New
-
Grant·A
EVP, CLO, CORP. SEC.
$0
29.6K sh
Own New
-
Grant·A
EVP, CLO, CORP. SEC.
$0
43.8K sh
Own +57%
-
Buy·P
Director
$653.5K
24.7K sh · $26.41
Own +17%
-
Buy·P
Director
$3.6M
142.5K sh · $25.44
Own New
-
Grant·A
Kevin Waters KEY
EVP, CFO
$0
3.5K sh
Own +3%
-
Grant·A
EVP, CLO, CORP. SEC.
$0
4.9K sh
Own +7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Dan Puckett | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Dan Puckett | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Thomas M Prescott | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Thomas M Prescott | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Frederic H Moll | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Frederic H Moll | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Elisabeth Sandoval Little | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Elisabeth Sandoval Little | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Taylor C. Harris | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Taylor C. Harris | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Amy M. Dodrill | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Amy M. Dodrill | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Antal Rohit Desai | Grant A | 5.9K | $0 |
| Jun 9, 2026 | Antal Rohit Desai | Grant A | 3.3K | $0 |
| Jun 8, 2026 | Kevin Waters KEY | Sell S | 357 | $10.2K |
| Jun 8, 2026 | Barry L Templin | Sell S | 358 | $10.2K |
| Jun 8, 2026 | Alaleh Nouri | Sell S | 285 | $8.1K |
| Mar 19, 2026 | Alaleh Nouri 10b5-1 | Sell S | 2.3K | $61.0K |
| Mar 19, 2026 | Alaleh Nouri 10b5-1 | Sell S | 3.0K | $78.3K |
| Mar 17, 2026 | Kevin Waters KEY | Sell S | 706 | $19.9K |
| Mar 17, 2026 | Alaleh Nouri | Sell S | 304 | $8.6K |
| Mar 10, 2026 | Alaleh Nouri | Sell S | 145 | $3.9K |
| Mar 10, 2026 | Alaleh Nouri | Sell S | 3.1K | $79.3K |
| Mar 9, 2026 | Antal Rohit Desai | Buy P | 1.3K | $33.0K |
| Mar 9, 2026 | Antal Rohit Desai | Buy P | 53.8K | $1.3M |
| Mar 9, 2026 | Antal Rohit Desai | Buy P | 43.6K | $1.0M |
| Mar 6, 2026 | Kevin Waters KEY | Sell S | 6.7K | $159.3K |
| Mar 6, 2026 | Alaleh Nouri | Sell S | 6.9K | $163.4K |
| Mar 6, 2026 | Antal Rohit Desai | Buy P | 53.8K | $1.3M |
| Mar 6, 2026 | Antal Rohit Desai | Buy P | 106.6K | $2.5M |
| Mar 6, 2026 | Frederic H Moll | Buy P | 501.3K | $2.0M |
| Mar 5, 2026 | Larry L Wood KEY | Grant A | 103.7K | $0 |
| Mar 5, 2026 | Larry L Wood KEY | Grant A | 127.8K | $0 |
| Mar 5, 2026 | Kevin Waters KEY | Grant A | 32.6K | $0 |
| Mar 5, 2026 | Kevin Waters KEY | Grant A | 47.5K | $0 |
| Mar 5, 2026 | Dan Puckett | Grant A | 8.9K | $0 |
| Mar 5, 2026 | Dan Puckett | Grant A | 5.5K | $0 |
| Mar 5, 2026 | Alaleh Nouri | Grant A | 29.6K | $0 |
| Mar 5, 2026 | Alaleh Nouri | Grant A | 43.8K | $0 |
| Mar 5, 2026 | Antal Rohit Desai | Buy P | 24.7K | $653.5K |
| Mar 5, 2026 | Antal Rohit Desai | Buy P | 142.5K | $3.6M |
| Feb 19, 2026 | Kevin Waters KEY | Grant A | 3.5K | $0 |
| Feb 19, 2026 | Alaleh Nouri | Grant A | 4.9K | $0 |
About PRCT insider trading
This page tracks insider transactions for PROCEPT BioRobotics Corp (PRCT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.